Haemonetics Corp (HAE) financials

Haemonetics Corp (HAE) revenue, EBIT and EBITDA, earnings per share, free cash flow, margins, debt and shareholders equity — annual and quarterly history, charted from SEC filings. No account needed.

In fiscal 2026, Haemonetics Corp reported revenue of $1.33B, down 2.0% year over year, net income of $97M, diluted EPS of $2.05 and free cash flow of $254M.

Revenue (fiscal 2026)

$1.33B

Revenue growth (fiscal 2026)

-2.0%

Net income (fiscal 2026)

$97M

Diluted EPS (fiscal 2026)

$2.05

Free cash flow (fiscal 2026)

$254M

Haemonetics Corp files with the U.S. Securities and Exchange Commission under CIK 0000313143, classified as Surgical & Medical Instruments & Apparatus.

Explore annual and quarterly revenue, earnings, cash flow, margins, debt and equity from SEC filings.